Sensitization to isobornyl acrylate in a tertiary Belgian hospital

Herman, Anne; Baeck, Marie

doi:10.1111/cod.13797

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the other IBOA-positive dermatitis patients no relevant exposure could be found. In previous studies sensitization to IBOA patch-tested at 0.1% concentration was also rare in general dermatitis patients (25,26). Even though sensitization to IBOA is rare in general dermatitis patients, it has proven a major sensitizer when used in MDs, such as CGMs and insulin pumps, where exposure is prolonged.…”

Section: Low Frequency Of Iboa Allergy Among Consecutive Dermatitis P...mentioning

confidence: 96%

Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices – A Retrospective Study from Southern Sweden

Ulriksdotter,

Sukakul,

Bruze

et al. 2024

Acta Derm Venereol

View full text Add to dashboard Cite

Allergic contact dermatitis is reported among individuals using continuous glucose monitoring systems and insulin pumps. The aim of this study was to describe contact allergy patterns for allergens in the Swedish baseline series and medical device-related allergens among users. Contact allergy to baseline series allergens and isobornyl acrylate was compared between diabetes patients and dermatitis patients patch-tested at the Department of Occupational and Environmental Dermatology during 2017 to 2020. Fifty- four diabetes patients and 2,567 dermatitis patients were included. The prevalence of contact allergy to fragrance mix II and sesquiterpene lactone mix was significantly higher in diabetes patients compared with dermatitis patients. Of the diabetes patients 13.0% and of the dermatitis patients 0.5% tested positive to sesquiterpene lactone mix (p < 0.001). Of the diabetes patients 7.4% and of the dermatitis patients 2.3% tested positive to fragrance mix II (p = 0.041). Of the diabetes patients 70.4% tested positive to medical device-related allergens. Of the diabetes patients 63.0% and of the dermatitis patients 0.2% were allergic to isobornyl acrylate (p < 0.001). In conclusion, not only medical device-related contact allergies, but also contact allergy to baseline series allergens (fragrance mix II and sesquiterpene lactone mix), is overrepresented in diabetes patients who use medical devices.

show abstract

Section: Low Frequency Of Iboa Allergy Among Consecutive Dermatitis P...mentioning

confidence: 96%

Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices – A Retrospective Study from Southern Sweden

Ulriksdotter,

Sukakul,

Bruze

et al. 2024

Acta Derm Venereol

View full text Add to dashboard Cite

show abstract

Sensitization to isobornyl acrylate in a tertiary Belgian hospital

Abstract: Highlights The sensitization rate to isobornyl acrylate in a patch‐tested population was evaluated at 0.6%. In this study, among patients sensitized to isobornyl acrylate, apart from glucose sensors and insulin pumps, no other sources of sensitization were identified.

Cited by 1 publication

References 7 publications

Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices – A Retrospective Study from Southern Sweden

Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices – A Retrospective Study from Southern Sweden

Contact Info

Product

Resources

About